Archive | October, 2009
Sunovia In Great Position To Take Off (OTC:SUNV)
Sunovia Energy Technologies, Inc. (OTC:SUNV), a Florida based company that commercializes LED and Solar Technologies, released a press release last month stating that they have Shattered the World Record Open Circuit Voltage (Voc) for Cadmium Telluride (CdTe) Thin Film Solar Cells by over 45%.
Continue reading...More tips for a better credit score
23 October 2009 – 6:00 am PST
Comments Off
Improving your credit score will pay off in lower interest rates, lower insurance rates, and better terms. Three major bureaus, Transunion, Equifax and Experian keep track of your credit history and scores. If your score isn’t what it should be here are a few more tips.
Continue reading...AstraZeneca and Bristol-Myers report mixed data (BMY, AZN)
22 October 2009 – 12:15 pm PST
Comments Off
It was just three weeks ago when AstraZeneca and Bristol-Myers Squibb came up with an announcement that their new diabetes drug named Dapagliflozin has come up with positive results in the late-stage trial that combined the therapy with metformin, a standard therapy.
Continue reading...Antigenics’ shares slide down (NASDAQ:AGEN)
22 October 2009 – 11:40 am PST
Comments Off
On Wednesday morning, Antigenics had a fresh round of bad news from European regulators announcing that they have rejected their new kidney cancer vaccine called Oncophage.
Continue reading...Pfizer Wyeth Collaboration Problems (NYSE:PFE)
21 October 2009 – 8:00 am PST
Comments Off
From the very first day when Pfizer and Wyeth announced their merger agreement, there has been a lot of commotion in the stock market at the same time concerns about how both this pharmaceutical giants will combine their teams of scientists and others employees working in the R&D unit.
Continue reading...Lupus Drug Data Fuels HGS (NASDAQ:HGSI)
21 October 2009 – 7:30 am PST
Human Genome Sciences Inc made an announcement that their experimental lupus drug has shown positive results and works faster that what they had expected from the drug.
Continue reading...Amgen faces FDA delays (NASDAQ:AMGN)
20 October 2009 – 8:00 am PST
Comments Off
On Monday morning Amgen Inc made an announcement that the Food and Drug Administration has issued them a Complete Response letter for the Biologic License Applications (BLA) for their new bone drug Denosumab (Prolia) for the treatment and prevention of postmenopausal osteoporosis.
Continue reading...FDA approves GSK’s Votrient (NYSE:GSK)
20 October 2009 – 7:00 am PST
Comments Off
It was a nice Monday morning for GSK when they made an announcement that the Food and Drug Administration has voted in the favor of their new cancer drug Votrient.
Continue reading...AstraZeneca’s Crestor Approved (NYSE:AZN)
19 October 2009 – 7:00 am PST
Comments Off
It was a good closing day for AstraZeneca as they announced that the Food and Drug Administration has approved Crestor (rosuvastatin calcium) for use in pediatric patients suffering from heterozygous familial hypercholesterolemia (HeFH).
Continue reading...Pfizer Management Blamed (NYSE:PFE)
17 October 2009 – 3:22 pm PST
Comments Off
A subsidiary of Pfizer, Pharmacia and Upjohn has been sentenced after pleading guilty to illegally promoting Bextra pain killers.
Continue reading...
23 October 2009 – 7:30 am PST
View Comments